Navigation Links
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
Date:12/3/2007

SEATTLE, Dec. 3 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (Nasdaq: TGEN) today reported on the National Institutes of Health (NIH) Recombinant DNA Advisory Committee's (RAC) assessment of the previously reported fatal serious adverse event (SAE) in the Phase I/II trial of tgAAC94 for inflammatory arthritis.

The Committee's opinion is that the subject's death was a result of complications from an opportunistic infection, disseminated histoplasmosis, which caused the study participant to experience a retroperitoneal hematoma and multi-organ failure. Further, the RAC observed that an apparent risk factor that may have had an impact on the patient's susceptibility to the infection was the patient's longstanding systemic treatment for rheumatoid arthritis with a TNF antagonist, adalimumab. The RAC indicated there was insufficient data available to determine if the patient may have had an immune response to the local injection of tgAAC94 as a part of the clinical trial in which she was participating. The panel also observed, however, that if there was an immune response to the intra-articular injection of tgAAV94 in this patient, it was very unlikely to have been a significant contributor, if at all, to the subject's clinical course and was not the cause of her death.

On October 23, 2007, upon comprehensive review of all available data, which were also presented at the American College of Rheumatology Annual Meeting on November 10, the study's independent data safety monitoring board concluded that the SAE was not related to the tgAAC94 product. In addition, as recently reported, the U.S. Food and Drug Administration (FDA) also released the trial from clinical hold, permitting the clinical trial
'/>"/>

SOURCE Targeted Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Study suggests brain tumors need treatment with multiple targeted drugs
2. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
3. Research suggests targeted treatment strategies for lupus
4. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
5. Genetics Hold Promise, Challenges for Cancer Care
6. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
7. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
8. Obesity genetics
9. The genetics of MLL leukemogenesis
10. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
11. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Bodybuilding.com, ... of nutritional supplements, has officially opened the polls for their eleventh annual ... following categories:, ,     Brand of the Year (BPI Sports) ...
(Date:8/3/2015)... , ... August 03, 2015 , ... The art of ... Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely eager ... decided to share her cookbook Recipes from My Persian Kitchen with the world. , ...
(Date:8/3/2015)... ... August 03, 2015 , ... It’s ... Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. The ... aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the Fall ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... is predicted to decline by 39 percent, according to market research compiled for ... includes data from the U.S. Department of Labor, Bureau of Labor Statistics. As ...
(Date:8/3/2015)... ... 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted to have an ... after many years of suffering and using medications with strong side effects. This had ... for extra time off or wait longer hours in the waiting rooms. Instead, he ...
Breaking Medicine News(10 mins):Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... ... Letters—for Temperature, Humidity and other Controlled Environments” , ... (Vocus) April 29, 2010 -- ... and other Controlled Environments” is now available from Veriteq ( www.veriteq.com ), ...
... beneficial, researchers say , THURSDAY, April 29 (HealthDay News) ... deep brain stimulation surgery in addition to treatment with ... the procedure, patients who underwent the surgery reported better ... and engage in routine daily activities compared to those ...
... , ... is a saying that seems to ring true according to husbands whose wives have had ... Surgery takes a look at the transformative journey from the husband,s perspective. , ... Newport Beach, Calif (Vocus) April 29, 2010 ...
... ... NeverTouch® laser fiber , ... Albany, N.Y. (PRWEB) April 29, 2010 -- AngioDynamics (NASDAQ: ANGO) announced today that ... expected to be featured in a segment on the popular television show "The Doctors.", ...
... ... of pool security results in the death of 100’s of children around the world. Despite it ... posing a serious risk. , ... 29, 2010 -- Du Toit & Associates plead to all swimming pool owners to follow swimming ...
... ... Awareness of Symptoms of Brain Aneurysms , ... Boston, MA (PRWEB) April 29, 2010 - On April 23, ... Seventy to eighty percent of spontaneous subarachnoid hemorrhages are caused by ruptured cerebral ...
Cached Medicine News:Health News:Guide for US FDA-Regulated Organizations Now Available 2Health News:Guide for US FDA-Regulated Organizations Now Available 3Health News:Adding Surgery to Meds May Improve Life With Parkinson's 2Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 2Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 3Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 4Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 2Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 3Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 4Health News:Du Toit & Associates Prepare to Prevent Silent Deaths by the Pool this Summer 2Health News:Early Detection Makes a Difference in the Treatment of Brain Aneurysms 2Health News:Early Detection Makes a Difference in the Treatment of Brain Aneurysms 3
(Date:8/3/2015)... Mass. , Aug. 3, 2015 Merrimack ... company will host its Second Quarter 2015 Investor Conference ... 10.    The call will cover an ... of second quarter 2015 financials. A press release detailing ... be issued the afternoon of Monday, August 10. Investors ...
(Date:8/3/2015)... JUPITER, Fla. , Aug. 3, 2015 /PRNewswire/ ... announced initiation of its second clinical development program ... drug candidate, CL-H1T.  CL-H1T contains ... is being developed as a treatment for migraine ... "Many patients with migraine headaches ...
(Date:8/3/2015)... -- Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: IMNP ), ... will present live at VirtualInvestorConferences.com on August 6, 2015. ... EDT LINK:    http://tinyurl.com/aug6-pre-imnp This ... are invited to ask the company questions in real-time ... the association,s "virtual trade booth." If attendees are not ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
... NEW YORK, Nov. 16 Personalized Pharmaceutical Systems (PPS) ... Guide to Viropharma Incorporated. , PPS is a ... developed advanced technology in phenomics to help drug companies ... a result help patients get the right drug the ...
... Leaders to Introduce Legislation , WASHINGTON , ... Network (ACPCN) will join congressional leaders tomorrow to introduce ... Act." The bill by U.S. Rep. G.K. Butterfield ... (PBM) companies for medications. , "Congress is prepared to ...
Cached Medicine Technology:Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated 2Pharmacists Work with Congress to Address PBM Abuses 2
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... Captia™ Legionella pneumophila IgG/IgM Enzyme-Linked ... for the qualitative detection of ... to Legionella pneumophila (Legionella) serogroups ... with clinical suspicion of Legionella ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: